Verastem

$Verastem(VSTM)$
RAS/MAPK同路在LGSOC野生型就是没啥效果，Dan非觉得自己明年RAMP301能做出来还额外入组病人在那大忽悠，然而希望很小。前段时间GOG 3026实验 来曲唑联合CDK4/6 mPFS14.5个月 orr30.6% 野生型病人完全可以选择后者数据差不多更便宜的疗法，因此市场预期变低。
但是LGSOC突...

$Verastem(VSTM)$ 是不是跌的有点多了，上市一季度卖了1100w，定价60w+ 年费用的品种，而这个疾病的生存期非常长，目前除了激素无药可治。26年环比数据应该非常好看，我觉得应该在 8kw-1.2亿美元之间。现在市值只有 4.5亿美元了。至于做不做 krasC 现在来看根本不重要啊

$Verastem(VSTM)$ 业绩比我想的差一点，但还是beat

在终止 RAMP 203 临床试验、暂停 KRAS G12C 项目后，$Verastem(VSTM) 明确将资源集中投向 KRAS G12D 抑制剂 VS-7375 的临床开发。这一转向并不意外，G12D靶点暂无成熟药出现，但是更高发突变型。
VS-7375 来源于$劲方医药-B(02595) ，目前已获得 FDA 快速通道资格，用于治疗 KRAS G12D 突变的...

$Verastem(VSTM)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-26-015353  Act: 34  Size: 10 KB 网页链接

$Verastem(VSTM)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001104659-26-023444  Act: 34  Size: 16 MB 网页链接

$Verastem(VSTM)$ Polar Capital Holdings Plc及其关联公司Polar Capital LLP和Polar Capital Funds PLC - Biotechnology Fund已提交了13G表格，报告了对Verastem, Inc.普通股的实际所有权。截至2025年12月31日，这些报告实体共同持有3,398,898.71股，占已发行股份的5.09%。此次持股的获得并非旨在...

$Verastem(VSTM)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-26-002135  Act: 34  Size: 9 MB 网页链接

$Verastem(VSTM)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001104659-26-010036  Act: 34  Size: 246 KB 网页链接

$Verastem(VSTM)$ 144 Report of proposed sale of securities Accession Number: 0001104659-26-003792  Act: 33  Size: 14 KB 网页链接

$Verastem(VSTM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-26-010891  Size: 5 KB 网页链接

$Verastem(VSTM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-26-033407  Size: 4 KB 网页链接

$Verastem(VSTM)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000102909-26-002525  Act: 34  Size: 7 KB 网页链接

$Verastem(VSTM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-26-003787  Size: 4 KB 网页链接

$Verastem(VSTM)$ 144 Report of proposed sale of securities Accession Number: 0001104659-26-003795  Act: 33  Size: 5 KB 网页链接

$Verastem(VSTM)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000902664-26-001148  Act: 34  Size: 12 KB 网页链接

$Verastem(VSTM)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001172661-26-001235  Act: 34  Size: 10 KB 网页链接

$Verastem(VSTM)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-26-023462  Act: 34  Size: 6 MB 网页链接

$Verastem(VSTM)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001172661-26-000002  Act: 34  Size: 10 KB 网页链接

$Verastem(VSTM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-26-006279  Size: 5 KB 网页链接